CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Trade Cooper - COO CFD

369.00
0.62%
0.43
Low: 366.91
High: 370.37
Market Trading Hours* (UTC) Opens on Tuesday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.43
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.025457 %
Charges from borrowed part ($-1.02)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.025457%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003235 %
Charges from borrowed part ($0.13)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.003235%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Cooper Companies Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 371.3
Open* 369.49
1-Year Change* 8.69%
Day's Range* 366.91 - 370.37
52 wk Range 244.22-395.20
Average Volume (10 days) 369.08K
Average Volume (3 months) 6.36M
Market Cap 18.27B
P/E Ratio 48.90
Shares Outstanding 49.46M
Revenue 3.38B
EPS 7.55
Dividend (Yield %) 0.01624
Beta 0.91
Next Earnings Date Jun 1, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 26, 2023 369.00 -1.91 -0.51% 370.91 372.24 366.46
May 25, 2023 371.30 -3.71 -0.99% 375.01 375.54 368.33
May 24, 2023 377.67 0.76 0.20% 376.91 379.11 371.93
May 23, 2023 379.74 -3.98 -1.04% 383.72 387.06 377.19
May 22, 2023 390.04 5.43 1.41% 384.61 394.43 384.50
May 19, 2023 384.23 -1.12 -0.29% 385.35 389.01 382.74
May 18, 2023 387.73 5.18 1.35% 382.55 389.66 382.55
May 17, 2023 385.43 -0.93 -0.24% 386.36 386.51 377.02
May 16, 2023 387.48 -0.83 -0.21% 388.31 388.31 383.14
May 15, 2023 389.19 0.65 0.17% 388.54 390.73 387.87
May 12, 2023 389.93 -0.18 -0.05% 390.11 393.27 386.32
May 11, 2023 391.59 4.30 1.11% 387.29 393.49 385.93
May 10, 2023 390.77 3.84 0.99% 386.93 395.01 386.86
May 9, 2023 385.06 2.92 0.76% 382.14 386.67 380.74
May 8, 2023 385.79 7.27 1.92% 378.52 387.62 378.52
May 5, 2023 385.75 6.57 1.73% 379.18 386.46 377.16
May 4, 2023 378.81 3.83 1.02% 374.98 381.38 372.76
May 3, 2023 380.49 0.85 0.22% 379.64 385.69 378.46
May 2, 2023 382.01 1.64 0.43% 380.37 383.49 375.31
May 1, 2023 383.47 5.76 1.52% 377.71 385.47 376.20

Cooper Events

Time (UTC) Country Event
Thursday, June 1, 2023

Time (UTC)

20:15

Country

US

Event

Q2 2023 Cooper Companies Inc Earnings Release
Q2 2023 Cooper Companies Inc Earnings Release

Forecast

-

Previous

-

Time (UTC)

21:00

Country

US

Event

Q2 2023 Cooper Companies Inc Earnings Call
Q2 2023 Cooper Companies Inc Earnings Call

Forecast

-

Previous

-
Thursday, June 8, 2023

Time (UTC)

18:00

Country

US

Event

Cooper Companies Inc at Jefferies Healthcare Conference
Cooper Companies Inc at Jefferies Healthcare Conference

Forecast

-

Previous

-
Tuesday, August 29, 2023

Time (UTC)

20:15

Country

US

Event

Q3 2023 Cooper Companies Inc Earnings Release
Q3 2023 Cooper Companies Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 3308.4 2922.5 2430.9 2653.4 2532.8
Revenue 3308.4 2922.5 2430.9 2653.4 2532.8
Cost of Revenue, Total 1142.1 966.7 896.1 896.6 900.5
Gross Profit 2166.3 1955.8 1534.8 1756.8 1632.3
Total Operating Expense 2800.8 2416.7 2119.1 2106.7 2129.7
Selling/General/Admin. Expenses, Total 1340 1134.2 966.2 969.5 973.3
Research & Development 110.3 92.7 93.3 86.7 84.8
Depreciation / Amortization 179.5 146.1 137.2 145.8 146.7
Operating Income 507.6 505.8 311.8 546.7 403.1
Interest Income (Expense), Net Non-Operating -31.6 -17 -38 -70.2 -86.1
Other, Net -0.7 2.7 -7.3 0.9 14.9
Net Income Before Taxes 475.3 491.5 266.5 477.4 331.9
Net Income After Taxes 385.8 2944.7 238.4 460.9 354.5
Minority Interest 0
Net Income Before Extra. Items 385.8 2944.7 238.4 460.9 354.5
Net Income 385.8 2944.7 238.4 466.7 139.9
Income Available to Common Excl. Extra. Items 385.8 2944.7 238.4 460.9 354.5
Income Available to Common Incl. Extra. Items 385.8 2944.7 238.4 466.7 139.9
Diluted Net Income 385.8 2944.7 238.4 466.7 139.9
Diluted Weighted Average Shares 49.7 49.8 49.6 50 49.7
Diluted EPS Excluding Extraordinary Items 7.76258 59.1305 4.80645 9.218 7.1328
Dividends per Share - Common Stock Primary Issue 0.06 0.06 0.06 0.06 0.06
Diluted Normalized EPS 8.40279 59.2728 5.28078 9.3744 7.45191
Unusual Expense (Income) 39.2 10.9 26.3 8.1 24.4
Total Extraordinary Items 0 5.8 -214.6
Other Operating Expenses, Total -10.3 66.1
Jan 2023 Oct 2022 Jul 2022 Apr 2022 Jan 2022
Total revenue 858.5 848.1 843.4 829.8 787.2
Revenue 858.5 848.1 843.4 829.8 787.2
Cost of Revenue, Total 300 303.9 289.6 279.9 268.8
Gross Profit 558.5 544.2 553.8 549.9 518.4
Total Operating Expense 709 744.6 702.8 697.1 656.4
Selling/General/Admin. Expenses, Total 299.1 356 341.4 333 309.6
Research & Development 31.6 29.1 28.7 26.3 26.2
Depreciation / Amortization 46.5 46 40.1 51.1 42.3
Unusual Expense (Income) 9.2 3.3 20.7 6
Operating Income 149.5 103.5 140.6 132.7 130.8
Interest Income (Expense), Net Non-Operating -25.1 -30.3 -22 30.6 -9.9
Other, Net -2.3 -0.8 -1.3 0.4 1
Net Income Before Taxes 122.1 72.4 117.3 163.7 121.9
Net Income After Taxes 84.6 65.6 98.4 126.6 95.3
Net Income Before Extra. Items 84.6 65.6 98.4 126.6 95.3
Net Income 84.6 65.6 98.4 126.6 95.3
Income Available to Common Excl. Extra. Items 84.6 65.6 98.4 126.6 95.3
Income Available to Common Incl. Extra. Items 84.6 65.6 98.4 126.6 95.3
Diluted Net Income 84.6 65.6 98.4 126.6 95.3
Diluted Weighted Average Shares 49.7 49.7 49.6 49.7 49.9
Diluted EPS Excluding Extraordinary Items 1.70221 1.31992 1.98387 2.54728 1.90982
Dividends per Share - Common Stock Primary Issue 0.03 0 0.03 0 0.03
Diluted Normalized EPS 1.70221 1.48764 2.03968 2.86939 2.00382
Other Operating Expenses, Total 31.8 0.4 -0.3 -13.9 3.5
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 1533.6 1465.3 1274.2 1163.4 1090.9
Cash and Short Term Investments 138.2 95.9 115.9 89 77.7
Cash & Equivalents 138.2 95.9 115.9 89 77.7
Total Receivables, Net 557.8 515.3 435.4 435.3 374.7
Accounts Receivable - Trade, Net 557.8 515.3 435.4 435.3 374.7
Total Inventory 628.7 585.6 570.4 506.9 468.8
Prepaid Expenses 208.9 179.3 152.5 132.2 169.7
Other Current Assets, Total 0 89.2
Total Assets 11492.3 9606.2 6737.5 6274.5 6112.8
Property/Plant/Equipment, Total - Net 1663 1604.6 1542.1 1132.1 976
Property/Plant/Equipment, Total - Gross 3050.2 2912.7 2735 2193.9 1930.3
Accumulated Depreciation, Total -1387.2 -1308.1 -1192.9 -1061.8 -954.3
Goodwill, Net 3609.7 2574 2447.3 2428.9 2392.1
Intangibles, Net 1885.1 1271.5 1289 1405.3 1521.3
Other Long Term Assets, Total 2800.9 2690.8 184.9 144.8 132.5
Total Current Liabilities 1280.2 732.1 1004.4 1110.6 536.5
Accounts Payable 248.8 161.4 176 150.1 146.4
Accrued Expenses 187.6 184.4 152.3 104.7 94
Notes Payable/Short Term Debt 395.7 82.9 59.4 63.7 37.1
Current Port. of LT Debt/Capital Leases 16.9 0 349.9 500
Other Current Liabilities, Total 431.2 303.4 266.8 292.1 259
Total Liabilities 4317.8 2664.4 2912.9 2646.1 2805.2
Total Long Term Debt 2350.8 1396.1 1383.9 1262.6 1985.7
Long Term Debt 2347.1 1396.1 1383.9 1262.6 1985.7
Deferred Income Tax 149.9 24.1 25.8 28 31
Minority Interest 0.2 0.2 0.2 0.2 0.2
Other Liabilities, Total 536.7 511.9 498.6 244.7 251.8
Total Equity 7174.5 6941.8 3824.6 3628.4 3307.6
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 5.4 5.4 5.3 5.3 5.3
Additional Paid-In Capital 1765.5 1715.2 1646.8 1615 1572.1
Retained Earnings (Accumulated Deficit) 6584.9 6202.1 3261.8 3026.4 2576
Treasury Stock - Common -714.5 -639.6 -617.3 -571.2 -415.1
Other Equity, Total -466.8 -341.3 -472 -447.1 -430.7
Total Liabilities & Shareholders’ Equity 11492.3 9606.2 6737.5 6274.5 6112.8
Total Common Shares Outstanding 49.3 49.3 49.1 49.1 49.2
Capital Lease Obligations 3.7
Jan 2023 Oct 2022 Jul 2022 Apr 2022 Jan 2022
Total Current Assets 1577.5 1533.6 1597.7 1738.2 1698.1
Cash and Short Term Investments 118.2 138.2 246.3 399.2 280.7
Cash & Equivalents 118.2 138.2 246.3 399.2 280.7
Total Receivables, Net 581.8 557.8 543.6 532 525.9
Accounts Receivable - Trade, Net 581.8 557.8 543.6 532 525.9
Total Inventory 659.1 628.7 621.6 603.8 588.1
Prepaid Expenses 218.4 208.9 186.2 203.2 196.6
Total Assets 11561.1 11492.3 11552.1 11778 11662.5
Property/Plant/Equipment, Total - Net 1464 1663 1601.3 1615.5 1629.5
Property/Plant/Equipment, Total - Gross 2800.9 2746.2 2719.1 2695.6
Accumulated Depreciation, Total -1387.2 -1384.9 -1353.5 -1334.1
Goodwill, Net 3672.3 3609.7 3665.8 3719.4 3835.7
Intangibles, Net 1863.4 1885.1 1917.3 1907.4 1842
Other Long Term Assets, Total 2983.9 2800.9 2770 2797.5 2657.2
Total Current Liabilities 915.8 1280.2 1375.7 1648.4 1664.4
Accounts Payable 224.1 248.8 227.2 184.1 149
Accrued Expenses 167.2 187.6 176.7 156.2 158.9
Notes Payable/Short Term Debt 51.6 395.7 74.6 905.7 912
Current Port. of LT Debt/Capital Leases 16.5 16.9 460 0 0
Other Current Liabilities, Total 456.4 431.2 437.2 402.4 444.5
Total Liabilities 4225.6 4317.8 4469.2 4764.4 4736.6
Total Long Term Debt 2627.3 2350.8 2346.9 2346.7 2346.5
Long Term Debt 2623.7 2347.1 2346.9 2346.7 2346.5
Deferred Income Tax 144.3 149.9 143.8 131.6 100.6
Minority Interest 0.2 0.2 0.2 0.2 0.2
Other Liabilities, Total 538 536.7 602.6 637.5 624.9
Total Equity 7335.5 7174.5 7082.9 7013.6 6925.9
Redeemable Preferred Stock 0 0 0 0
Common Stock 5.4 5.4 5.4 5.4 5.4
Additional Paid-In Capital 1779.2 1765.5 1751 1736.8 1719.2
Retained Earnings (Accumulated Deficit) 6668 6584.9 6519.4 6422.5 6295.9
Treasury Stock - Common -713.3 -714.5 -715.6 -716.6 -717.4
Other Equity, Total -403.8 -466.8 -477.3 -434.5 -377.2
Total Liabilities & Shareholders’ Equity 11561.1 11492.3 11552.1 11778 11662.5
Total Common Shares Outstanding 49.4 49.3 49.3 49.3 49.2
Other Current Assets, Total 0 0 0 106.8
Capital Lease Obligations 3.6 3.7
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 385.8 2944.7 238.4 466.7 139.9
Cash From Operating Activities 692.4 738.6 486.6 713.2 668.9
Cash From Operating Activities 346.1 309.3 287.1 280.8 275.1
Deferred Taxes 53.9 -2502.2 -0.9 -15.9 2.9
Non-Cash Items 80.6 136.7 87.8 21.7 131.4
Cash Taxes Paid 66.6 63.2 51.1 39.2 18.8
Cash Interest Paid 49.1 28.4 46.5 75.3 82.1
Changes in Working Capital -174 -149.9 -125.8 -40.1 119.6
Cash From Investing Activities -1831.2 -450.3 -364.5 -351.3 -1517.5
Capital Expenditures -242 -214.4 -310.4 -292.1 -193.6
Other Investing Cash Flow Items, Total -1589.2 -235.9 -54.1 -59.2 -1323.9
Cash From Financing Activities 1193.7 -311.4 -95.5 -351.4 844.4
Financing Cash Flow Items -10.8 20.4 -10.3 7.4 -2.3
Total Cash Dividends Paid -3 -3 -3 -3 -2.9
Issuance (Retirement) of Stock, Net -71.3 -19 -45.1 -156.1 0
Issuance (Retirement) of Debt, Net 1278.8 -309.8 -37.1 -199.7 849.6
Foreign Exchange Effects -12.9 2.9 0.7 -1.2 -4.4
Net Change in Cash 42 -20.2 27.3 9.3 -8.6
Jan 2023 Oct 2022 Jul 2022 Apr 2022 Jan 2022
Net income/Starting Line 84.6 385.8 320.2 221.8 95.3
Cash From Operating Activities 166.6 692.4 561.7 297.8 166
Cash From Operating Activities 89.7 346.1 257.1 175.4 82
Deferred Taxes 53.9 55 35.6 14.7
Changes in Working Capital 24.1 -83.1 -59.9 -135 -26
Cash From Investing Activities -113.3 -1831.2 -1731.5 -1685 -1669.3
Capital Expenditures -83 -242 -147.1 -100.5 -57.1
Other Investing Cash Flow Items, Total -30.3 -1589.2 -1584.4 -1584.5 -1612.2
Cash From Financing Activities -77.6 1193.7 1327.8 1696.5 1693.6
Financing Cash Flow Items -3.4 -10.8 -13.7 -13.2 -14.3
Total Cash Dividends Paid -3 -1.5 -1.5
Issuance (Retirement) of Stock, Net 1.8 -71.3 -73.1 -75.1 -76.9
Issuance (Retirement) of Debt, Net -76 1278.8 1416.1 1786.3 1784.8
Foreign Exchange Effects 4.2 -12.9 -8 -6.3 -3.7
Net Change in Cash -20.1 42 150 303 186.6
Non-Cash Items -31.8 -10.3 -10.7
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 11.3411 5608811 48831 2023-03-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.8496 2398408 80571 2023-03-31 LOW
Veritas Asset Management LLP Investment Advisor/Hedge Fund 4.2235 2088761 -3083 2023-03-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.1957 2074996 -30339 2023-03-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 4.0107 1983538 -489876 2023-03-31 MED
Generation Investment Management LLP Investment Advisor/Hedge Fund 3.2942 1629154 -12414 2023-03-31 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 3.1658 1565656 -7090 2023-03-31 LOW
Kayne Anderson Rudnick Investment Management, LLC Investment Advisor 3.0971 1531670 25335 2023-03-31 LOW
Victory Capital Management Inc. Investment Advisor/Hedge Fund 2.4677 1220393 21700 2023-03-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.0465 1012111 22595 2023-03-31 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 1.898 938664 -104801 2023-03-31 LOW
JP Morgan Asset Management Investment Advisor 1.749 864967 -59805 2023-03-31 LOW
Allianz Global Investors GmbH Investment Advisor 1.3246 655104 -7483 2023-03-31 LOW
MFS Investment Management Investment Advisor/Hedge Fund 1.2985 642188 -71190 2023-03-31 LOW
Newton Investment Management Ltd. Investment Advisor 1.2907 638325 -12887 2023-03-31 LOW
Millennium Management LLC Hedge Fund 1.2767 631384 146125 2023-03-31 HIGH
Bessemer Trust Company, N.A. (US) Investment Advisor 1.1275 557615 1053 2023-03-31 LOW
Fidelity International Investment Advisor 1.0129 500947 10198 2023-03-31 LOW
Macquarie Investment Management Investment Advisor 0.9932 491176 125113 2023-03-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.9722 480817 92715 2023-03-31 LOW

Start a global, multi-asset portfolio with an award-winning platform

Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Cooper Company profile

About Cooper Companies Inc

The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Financial summary

BRIEF: For the three months ended 31 January 2022, Cooper Companies Inc revenues increased 16% to $787.2M. Net income decreased 95% to $95.3M. Revenues reflect CooperVision segment increase of 11% to $561.5M, CooperSurgical segment increase of 30% to $225.7M, United States segment increase of 17% to $365.3M, Europe segment increase of 13% to $250.4M, Rest of the World segment increase of 17% to $171.5M.

Equity composition

Common Stock $.10 Par, 1/11, 70M auth., 46,473,000 issd., less 282,000 shs. in Treas. @ $4.3M. Insiders & Strategic Owns 0.70%. PO7/97,2M shs. @ $23.50 by Deutsche Morgan Grenfell. 11/02, 2-for-1 split; 9/95, 1-for-3 reverse stock split. FY'05 Qs are being restated. Summ. Q's reflect RES for FY'05.

Industry: Glasses, Spectacles & Contact Lenses

6101 Bollinger Canyon Road
Suite 500
SAN RAMON
CALIFORNIA 94583
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

14,350.10 Price
+0.160% 1D Chg, %
Long position overnight fee -0.0255%
Short position overnight fee 0.0032%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.50 Price
+3.920% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00377

Oil - Crude

72.46 Price
-0.620% 1D Chg, %
Long position overnight fee -0.0146%
Short position overnight fee -0.0073%
Overnight fee time 21:00 (UTC)
Spread 0.03

BTC/USD

27,870.05 Price
+1.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

Still looking for a broker you can trust?

Join the 530.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading